Syria's essential medicine list 2019
ANNEX 1 |
|||
Essential Medicines List 2019 |
|||
Item |
Description |
Needs 2019 |
|
1.ANAESTHETICS |
|
|
|
Atropine |
Injection: 1 mg (sulfate) in 1-ml ampoule |
300000 |
|
Fentanyl |
Injection: 0.05 mg fentanyl/mL vial |
200000 |
|
Halothane |
Inhalation |
5000 |
|
Isoflurane |
Inhalation |
25000 |
|
Ketamine |
Injection: 50 mg (as hydrochloride)/ml in 10-ml vial |
100000 |
|
Nitrous oxide |
Inhalation |
5000 |
|
Oxygen |
Inhalation (medicinal gas) |
50000 |
|
Propofol* |
Injection: 10 mg/ml, 50ml |
250000 |
|
Propofol* |
Injection: 20 mg/ml, 20 ml |
50000 |
|
Thiopental |
Injection: 1g |
100000 |
|
Sevoflurane bottle (quick fill bottle adapter ) |
Inhalation |
25000 |
|
1.2 Local anesthetics |
|
|
|
Bupivacaine |
|
50000 |
|
2.ANALGESICS, ANTIPYRETICS, NSAID, MEDICINES USED TO TREST GOUT AND DISEASE MODYFYING AGENT IN RHEUMATOID DISORDERS (DMARDs) |
|
||
Diclofenac sodium |
Tablet: 75mg |
500000 |
|
Diclofenac sodium |
Injection: 75mg Ampoule |
700000 |
|
Ketorolac |
Injection |
50000 |
|
Paracetamol |
Injection:10mg/ml, 100ml v vial |
700000 |
|
Paracetamol |
Inj IM |
700000 |
|
Paracetamol |
Tablet: 500 mg |
0 |
|
Paracetamol |
Suppository 125mg |
0 |
|
Acetyl salicylic Acid |
Tablets 500mg |
0 |
|
Sulfasalazine |
Tablet: 500 mg |
100000 |
|
Tramadol |
Tablet: 50 mg |
0 |
|
Tramadol |
Injection: 50mg in 2ml amp |
100000 |
|
2.3 Medicines for other common symptoms in palliative care |
|
||
loperamide |
Solid oral dosage form: 2 mg. |
5000 |
|
2.4 MEDICINES USED IN PALLIATIVE CARE |
|
|
|
Amitriptyline |
Tablet: 10 mg |
200000 |
|
Amitriptyline |
Tablet: 25 mg |
400000 |
|
Fluoxetine |
Solid oral dosage form: 20 mg (as hydrochloride) |
150000 |
|
Hyoscine hydrobromide |
Injection: 400 micrograms/ml |
200000 |
|
Hyoscine hydrobromide |
Injection: 600 micrograms/ml |
200000 |
|
Ibuprofen |
Oral liquid: 200 mg/5 ml |
150000 |
|
Ibuprofen |
Tablet: 200 mg |
150000 |
|
Ibuprofen |
Tablet: 400 mg |
150000 |
|
Ibuprofen |
Tablet: 600 mg |
150000 |
|
Midazolam |
Injection: 1 mg/ml |
20000 |
|
Midazolam |
Injection: 5 mg/ml |
75000 |
|
3.ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS |
|||
Dexamethasone |
Tablet: 0.5 mg |
100000 |
|
Dexamethasone |
Tablet: 1.5 mg |
100000 |
|
Dexamethasone |
Injection: 4 mg/ml ampoule |
100000 |
|
Epinephrine (adrenaline) |
Injection: 1 mg (as hydrochloride or hydrogen tartrate) in 1ml apoule |
300000 |
|
Noradrenaline |
Injection: 1 mg in 1 ml |
150000 |
|
Prednisolone |
Tablet: 5mg |
50000 |
|
Prednisolone |
Tablet: 20 mg |
50000 |
|
4.ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS |
|||
Calcium gluconate |
Injection: 100mg/ml in 10 ml ampoule |
300000 |
|
Charcoal activated |
CAPS/TABS |
10000(dose) |
|
Dimercaprol |
Injection: 50mg/ml -2ml ampoule |
5000 |
|
Naloxone |
Injection: 400 microgramme ampoule 1ml |
5000 |
|
Sodium calcium edetate |
Injection: 50mg/ml -2ml ampoule |
1000 |
|
5.ANTICONVULSANTS/ ANTIEPILEPTICS |
|||
Diazepam |
Tablet: 2mg |
75000 |
|
Diazepam |
Tablet: 5mg |
50000 |
|
Diazepam |
Tablet: 10mg |
100000 |
|
Diazepam |
Suppository:10mg |
20000 |
|
Diazepam |
Injection: 10mg/amp (intervenous) |
100000 |
|
Phenobarbital |
Injection: 200 mg/ml (sodium) |
10000 |
|
Phenobarbital |
Tablet: 15mg |
50000 |
|
Phenytoin |
Tablet (chewable): 50 mg |
50000 |
|
Phenytoin |
Injection: 250mg/5ml- ampoule |
20000 |
|
ethosuximide |
Oral liquid: 250 mg/5 mL. |
0 |
|
lorazepam |
Parenteral formulation: 2 mg/ mL in 1‐ mLampoule |
15000 |
|
magnesium sulfate* |
Injection: 0.5g/ mL in 2‐ mL ampoule (equivalent to1 g in 2 mL; 50% weight/volume |
15000 |
|
magnesium sulfate* |
0.5g/ mL in10‐ mL ampoule (equivalent to 5 g in 10 mL; 50%weight/volume) |
15000 |
|
6.ANTI-INFECTIVE MEDICINES |
|||
6.1 ANTIHELMENTHICS |
|
|
|
Pyrantel |
Suspension: 250mg/5ml |
20000 |
|
6.1.1 Intestinal anthelminthic |
|
|
|
Albendazole |
Tablet (chewable): 400 mg. |
25000 |
|
6.2 ANTIBACTERIALS |
C |
|
|
Amoxicillin |
Oral liquid : 250mg / 5ml- bottle -100 ml |
300000 |
|
Amoxicillin |
Tablet: 500mg |
2000000 |
|
Amoxicillin + Calvulanic acid |
Syrup: 250mg/5ml |
600000 |
|
Amoxicillin + Calvulanic acid |
Tablet: 500mg +125 mg |
1000000 |
|
Amoxicillin + Calvulanic acid |
Powder for injection: 1gr+200 mg vial |
2000000 |
|
Ampicillin |
Powder for injection: 1g |
100000 |
|
Benzathine benzylpenicillin |
Powder for injection: 0,6million IU in 5ml vial |
10000 |
|
Benzathine benzylpenicillin |
Powder for injection: 1.2 million IU in 5-ml vial |
10000 |
|
Benzylpenicillin G |
Powder for injection: 3 g ( 5 million IU) in vial |
2000 |
|
Benzylpenicillin G |
Powder for injection: 600 mg (1 million IU) in vial |
10000 |
|
Cefalexin |
Syrup: 250mg/5ml - bottle 100 ml |
15000 |
|
Cefotaxime |
Injection 1 g vial |
200000 |
|
Ceftriaxone |
Injection: 1g vial |
1000000 |
|
Ceftriaxone |
Injection: 2g vial |
30000 |
|
Ceftriaxone |
Injection: 500mg vial |
500000 |
|
Ciprofloxacin |
Tablet: 500mg |
25000 |
|
Ciprofloxacin |
Tablet: 250mg |
50000 |
|
Ciprofloxacin |
Injection : 200mg vial |
25000 |
|
Clarithromycin |
Powder for injection : 500 mg |
100000 |
|
Clarithromycin |
Tablets 500mg |
50000 |
|
Colimycin |
Injection : 1000.000 IU vial |
100000 |
|
Doxycycline |
Tablet : 100mg |
400000 |
|
Fucidic acid |
Infusion vial |
5000 |
|
Cotrimoxazol |
Injection |
500000 |
|
Metronidazol |
Infusion vial : 500mg |
500000 |
|
Metronidazol |
Tablets 500mg |
25000 |
|
Metronidazol |
Tablets 200 |
25000 |
|
Metronidazol |
Susp 200mg/5ml |
50000 |
|
Ofloxacin |
Tablet: 200mg |
20000 |
|
Phenoxymethylpenicillin |
Powder for oral liquid: 250 mg (as potassium salt)/5 ml |
50000 |
|
Phenoxymethylpenicillin |
Tablet: 250mg |
500000 |
|
Rifampicin |
Syrup 60ml |
15000 |
|
Rifampicin |
Capsule: 300mg |
1000000 |
|
Spiramycin + metronidazole |
Tablet : 1,5 M+ 500mg |
20000 |
|
Teicoplanin |
Injection: 400 mg vial |
50000 |
|
Teicoplanin |
Injection: 200mg vial |
50000 |
|
Vancomycin |
Powder for injection: 500 mg |
200000 |
|
6.2.1 Beta-lactam medicines |
|
|
|
cefazolin |
Powder for injection: 1 g (as sodium salt) in vial. |
150000 |
|
cefixime |
Capsule: 400 mg (as trihydrate). |
500000 |
|
ceftazidime |
Powder for injection: 1 g (as pentahydrate)in vial |
200000 |
|
ceftazidime |
Powder for injection: 250 mg (as pentahydrate)in vial. |
25000 |
|
cloxacillin |
Powder for oral liquid: 125 mg (as sodiumsalt)/5 mL. |
100000 |
|
cloxacillin |
Powder for injection: 500 mg (as sodium salt) in vial |
6000 |
|
cloxacillin |
Capsule: 500 mg |
0 |
|
imipenem + cilastatin |
Powder for injection: 250 mg (as monohydrate) +250 mg (as sodium salt); |
100000 |
|
imipenem + cilastatin |
500 mg (as monohydrate) +500 mg (as sodium salt) in vial |
100000 |
|
Piperacillin+Tazobactam |
Inj :4gr +500mg |
50000 |
|
6.2.2 Other antibacterial |
|
|
|
clindamycin |
Injection: 150 mg (as phosphate)/ mL. |
5000 |
|
clindamycin |
Oral liquid: 75 mg/5 mL (as palmitate) |
10000 |
|
chloramphenicol |
Powder for injection: 1 g (sodium succinate) in vial. |
1000 |
|
Doxycycline |
Solid oral dosage form: 50 mg [c]; 100 mg (as hyclate). |
150000 |
|
nitrofurantoin |
Oral liquid: 25 mg/5 mL |
20000 |
|
nitrofurantoin |
Tablet: 100 mg. |
100000 |
|
erythromycin |
Solid oral dosage form: 250 mg (as stearate orestolate or ethyl succinate). |
10000 |
|
erythromycin |
Powder for oral liquid: 125 mg/5 mL (as stearate orestolate or ethyl succinate). |
50000 |
|
sulfamethoxazole + trimethoprim |
Tablet :400 mg + 80 mg |
25000 |
|
sulfamethoxazole + trimethoprim |
Oral liquid: 200 mg + 40 mg/5 mL. |
100000 |
|
6.3 ANTI-FUNGAL MEDICINES |
|||
Amphotericine B |
Powde for injection: 50mg in vial as sodium deoxycholate |
10000 |
|
Clotrimazole |
Vaginal cream 1% |
50000 |
|
Clotrimazole |
Vaginal tablet: 100, 500 mg |
50000 |
|
Miconazole |
Cream |
20000 |
|
Miconazole 150mg+ metronidazole 500mg |
Vaginal tablet: 500 mg |
25000 |
|
Nystatine |
Tablet: 100.000 IU |
50000 |
|
Nystatine |
Oral liquid: 50mg / 5ml |
20000 |
|
Nystatine+neomycine+polymycin B |
Vaginal ovule |
15000 |
|
fluconazole |
Injection: 2 mg/ mL in vial |
25000 |
|
griseofulvin |
Solid oral dosage form: 125 mg; |
5000 |
|
6.4 ANTI-VIRAL |
|||
Acyclovir |
250 inj |
50000 |
|
Acyclovir |
500 inj |
50000 |
|
Amantadine |
Capsule: 100mg |
5000 |
|
6.4.4.2.5 Other antivirals |
|||
Pegylated interferon alfa (2a or 2b) |
180 micrograms (peginterferon alfa‐2a), |
|
|
6.5.4 Antipneumocystosis and antitoxoplasmosis medicines |
|||
sulfadiazine |
Tablet: 500 mg |
0 |
|
8.ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE |
|
||
8.1 IMMUNOSUPPRESSIVE MEDICINES |
|||
Mycophenolate mofetil |
Tablet: 500 mg |
900000 |
|
Tacrolimus |
Tablet: 0.5mg |
100000 |
|
Tacrolimus |
Tablet: 1mg |
1000000 |
|
ATG anti tissue |
Injection 50mg |
100 |
|
ATG anti tissue |
Injection 100mg |
100 |
|
Azathioprine |
Tablet: 50 mg |
900000 |
|
Cyclosporin |
capsule: 25 mg |
400000 |
|
Cyclosporin |
capsule: 50 mg |
500000 |
|
Cyclosporin |
capsule: 100mg |
100000 |
|
8.2 CYTOTOXIC AND ADJUVANT MEDICINES |
|||
Asparaginase |
Powder for injection: 10 000 IU in via |
3000 |
|
Bleomycin |
Powder for injection: 15 mg (as sulfate) in vial |
6000 |
|
Bendamustin |
Perf 25mg |
2600 |
|
Bendamustin |
Perf 100mg |
2300 |
|
Retinoic Acid ( All trans) |
10mg/ Caps |
3000 |
|
Calcium folinate |
Injection : 5 mg/ml in 10-ml ampoule |
30000 |
|
Calcium folinate |
Injection : 30 mg vials |
20000 |
|
Calcium folinate |
Injection : 100 mg vials |
25000 |
|
Calcium folinate |
Tablet : 15 mg |
0 |
|
Capecitabin |
Tablet : 150 mg |
0 |
|
Capecitabin |
Tablet : 500 mg |
720000 |
|
Carboplatin |
Injection : 150 mg/15 ml |
25000 |
|
Carboplatin |
Injection : 450 mg/45 ml |
20000 |
|
Chlorambucil |
Tablet : 2 mg |
40000 |
|
Cisplatine |
Injection : 50mg vial |
25000 |
|
Cisplatine |
Injection : 25mg vial |
5000 |
|
Cyclophosphamide |
Powder for injection: 200 mg in vial |
11000 |
|
Cyclophosphamide |
Powder for injection: 1000 mg in vial |
15000 |
|
Cyclophosphamide |
Tablet : 25 mg |
15000 |
|
Cytarabine |
Powder for injection: 100 mg in vial |
15000 |
|
Cytarabine |
Powder for injection: 1g in vial |
15000 |
|
Dacarbazine |
Powder for injection: 100 mg in vial |
5000 |
|
Dacarbazine |
Powder for injection: 200 mg in vial |
10000 |
|
Dasatinib |
Tab 50mg |
24000 |
|
Dasatinib |
Tab 100mg |
24000 |
|
D-Actinomycine |
Injection 0,5 mg vials |
600 |
|
Daunorubicin |
Powder for injection:20 mg (hydrochloride) in vial |
2500 |
|
Docetaxel |
Injection 20mg |
25000 |
|
Docetaxel |
Injection 80mg |
15000 |
|
Doxorubicin |
Powder for injection: 10 mg (hydrochloride) in vial |
6000 |
|
Doxorubicin |
Powder for injection: 50 mg (hydrochloride) in vial |
25000 |
|
Etoposide |
Capsule: 100 mg |
5000 |
|
Etoposide |
Capsule: 50 mg |
2000 |
|
Etoposide |
Injection: 20 mg/ml in 5-ml ampoule |
20000 |
|
Filgrastim |
Injection 120 mcg Vials |
1700 |
|
Filgrastim |
Injection 300mcg vials |
40000 |
|
Filgrastim |
Injection 480 mcg |
7000 |
|
Fludarabin (phosphate) |
Inj 50mg Vial |
2000 |
|
Flurouracil |
Injection : 50 mg/ml in 5-ml ampoule |
52000 |
|
Flurouracil |
Injection : 100 mg/ml in 5-ml ampoule |
75000 |
|
Gemcitabine |
Injection 200 mg vials |
25000 |
|
Gemcitabine |
Injection 1gr 25 ml |
20000 |
|
Imatinib |
Tablets 100mg |
80000 |
|
Imatinib |
Tablets 400mg |
300000 |
|
Irinotecan |
Injection 40 mg vials |
3000 |
|
Irinotecan |
Injection 100mg vials |
5000 |
|
Hydroxycarbamide |
Solid oral dosage form:500 mg |
250000 |
|
Ifophosphamide |
Powder for injection: 1 g vial |
10000 |
|
Ifophosphamide |
Powder for injection: 2 g vial |
5000 |
|
Mercaptopurine |
Tablet : 50 mg |
100000 |
|
Tamoxifen (as citrate) |
Tab 10mg |
0 |
|
Tamoxifen (as citrate) |
Tab 20mg |
0 |
|
Trastuzumab |
Tab 150 mg |
8000 |
|
Trastuzumab |
Tab 440 mg |
10000 |
|
Uromitexan- Mesna |
Injection: 100 mg/ml in 4-ml and 10-ml ampoules |
35000 |
|
Uromitexan- Mesna |
Tablet : 400 mg |
0 |
|
Uromitexan- Mesna |
Tablet : 600 mg |
0 |
|
Methotrexate |
Injection : 50 mg/ml ampoule |
2500 |
|
Methotrexate |
Injection : 500 mg/ml ampoule |
1500 |
|
Methotrexate |
Tablet: 2.5 mg (as sodium salt) |
250000 |
|
Nilotinib |
150 mg / tab |
400 |
|
Nilotinib |
200 mg / tab |
26400 |
|
Oxaliplatin |
Injection 50 mg vials |
15000 |
|
Oxaliplatin |
Injection 100 mg vials |
15000 |
|
Paclitaxel |
Infusion for injection : 300 mg |
10000 |
|
Paclitaxel |
Infusion for injection : 150 mg |
10000 |
|
Rituximab |
Injection 100 mg vials |
7000 |
|
Rituximab |
Injection 500 mg vials |
6000 |
|
Thioguanine [c] |
Solid oral dosage form: 40 mg |
0 |
|
Vinblastine |
Powder for injection: 10 mg (sulfate) in vial |
2500 |
|
Vincristine |
Powder for injection: 1 mg (sulfate) in vial |
10000 |
|
Vincristine |
Powder for injection: 2 mg (sulfate) in vial |
3000 |
|
Vinorelbin |
Inj 10 mg/ml amp 1ml |
5000 |
|
Vinorelbin |
Inj 50 mg/5ml amp 5ml |
5000 |
|
Vinorelbin |
Caps 20mg |
5000 |
|
Vinorelbin |
Caps 30mg |
5000 |
|
Zoledronic Acid |
Infusion 4mg/100ml |
3000 |
|
8.2 CYTOTOXIC AND ADJUVANT MEDICINES |
|||
Allopurinol |
Tablet: 100 mg |
100000 |
|
Allopurinol |
Tablet: 300 mg |
100000 |
|
8.3 HORMONES AND ANTIHORMONES |
|||
Hydrocortisone |
Powder for injection: 100 mg (as sodium succinate) in vial |
100000 |
|
Methylprednisolone |
Injection: 40 mg/ml (as sodium succinate) in 1-ml single dose vial |
1000 |
|
Methylprednisolone |
Injection: 125 mg/ml (as sodium succinate) in 1-ml single dose vial |
0 |
|
Methylprednisolone |
Injection: 500 mg/ml (as sodium succinate) in 1-ml single dose vial |
5000 |
|
Methylprednisolone |
Injection: 1000 mg/ml (as sodium succinate) in 1-ml single dose vial |
5000 |
|
Prednisolone |
Tablet: 5mg |
0 |
|
Prednisolone |
Tablet: 20mg |
0 |
|
Prednisolone |
Oral liquid: 5 mg/ml |
0 |
|
9.ANTIPARKINSONISM MEDICINES |
|||
Levodopa + Carbidopa ( SR) |
Tablet: 100 mg + 10 mg |
50000 |
|
Levodopa + Carbidopa( SR) |
Tablet: 250 mg + 25 mg |
100000 |
|
Biperiden |
Tablet: 2 mg (hydrochloride). |
0 |
|
10.MEDICINES AFFECTING THE BLOOD |
|||
10.1 ANTIANAEMIA MEDICINES |
|||
Deferoxamine* |
Powder for injection: 500 mg (mesilate) in vial |
225000 |
|
Erythropoietin |
Injection: 4000IU-vial |
61000 |
|
Erythropoietin |
Injection: 10000IU-vial |
25000 |
|
Ferrous salt |
Oral liquid: equivalent to 25 mg iron (as sulfate)/ml |
0 |
|
Ferrous salt |
Tablet: equivalent to 60 mg iron |
0 |
|
Ferrous salt + Folic acid |
Tablet equivalent to 60 mg iron + 400 micrograms folic acid |
0 |
|
Folic acid |
Tablet: 1 mg |
500000 |
|
Folic acid |
Tablet: 5 mg |
500000 |
|
Heparin sodium |
Injection: 1000 IU/ml |
0 |
|
Heparin sodium |
Injection: 5000 IU/ml |
50000 |
|
Heparin sodium |
Injection: 25 000 IU/ml |
60000 |
|
Hydroxocobalamin |
Injection: 1 mg (as acetate, hydrochloride or as sulfate) in 1-ml ampoule. |
10000 |
|
Low- molecular-weight heparin(LMWH) |
2500 IU single dose préventive |
100000 |
|
Low- molecular-weight heparin(LMWH) |
4000 IU single dose préventive |
160000 |
|
Low- molecular-weight heparin(LMWH) |
6000 IU single dose préventive |
160000 |
|
Low- molecular-weight heparin(LMWH) |
10000 IU single dose curative |
50000 |
|
Protamine sulfate |
Injection: 10 mg/ml in 5-ml ampoule |
35000 |
|
Warfarin |
Tablet: 1 mg (sodium salt) |
1000 |
|
Warfarin |
Tablet: 2 mg (sodium salt) |
50000 |
|
Warfarin |
Tablet: 5 mg (sodium salt) |
600000 |
|
10.2 Medicines affecting coagulation |
|||
Desmopressin |
Injection: 4 micrograms/ mL (as acetate) in 1‐ mL ampoule. |
10000 |
|
Desmopressin |
Nasal spray: 10 micrograms (as acetate) per dose |
10000 |
|
Tranexamic acid |
Injection: 100 mg/ mL in 10‐ mL ampoule. |
35000 |
|
11.BLOOD PRODUCTS AND PLASMA SUBSTITUTES |
|||
11.1 PLASMA SUBSTITUTES |
|||
Dextran 70* |
Injectable solution: 6% |
0 |
|
Dextran 70* |
* Polygeline, injectable solution, 3.5% is considered as equivalent. |
10000 |
|
Albumin |
|
200000 |
|
Factor VIII concentrate |
500 IU |
10000 |
|
Factor VIII concentrate |
1000 IU |
5000 |
|
Factor IX complex concentrate |
dried |
2800 |
|
Interferon α 2B |
Injection: 10 million IU vial |
1200 |
|
Interferon α 2B |
Injection: 5 million IU vial |
600 |
|
Interferon α 2B |
Injection: 3 millions IU |
1200 |
|
Interferon Beta 1A |
Injection 22mcg |
2000 |
|
Interferon Beta 1A |
Injection 44mcg |
50000 |
|
Interferon Beta 1A |
Injection 30mcg |
37000 |
|
Intravenous immunoglobulin (IVIG) |
Injection: 3g vial |
1500 |
|
Intravenous immunoglobulin (IVIG) |
Injection: 6g vial |
1000 |
|
12.CARDIOVASCULAR MEDICINES |
|||
12.1 Antianginal medicines |
|||
Bisoprolol |
Tablet: 5 mg. |
1000000 |
|
Acetylsalicylic acid - cardiac dosage |
Tablet: 100 mg |
100000 |
|
Amiodarone |
Injection: 50 mg/ml in 3-ml ampoule (hydrochloride) |
50000 |
|
Amlodipine |
Tablet: 5 mg (as maleate, mesylate or besylate) |
200000 |
|
Atenolol |
Tablet: 50mg |
500000 |
|
Atenolol |
Tablet: 100mg |
500000 |
|
Clopidogrel |
Tablet: 75mg |
200000 |
|
Digoxin |
Injection: 250 micrograms/ml in 2-ml ampoule |
15000 |
|
Digoxin |
Tablet: 250 micrograms |
200000 |
|
Dobutamine |
Injection: 250mg/20ml solution for infusion ampoule |
25000 |
|
Dopamine |
Injection: 40 mg/ml (hydrochloride) in 5-ml vial |
100000 |
|
Enalapril |
Tablet: 5 mg (as hydrogen maleate) |
100000 |
|
Furosemide |
Tablet: 40 mg |
100000 |
|
Furosemide |
Tablet: 500 mg |
3000 |
|
Furosemide |
Injection: 20mg/2ml - 2ml ampoule |
500000 |
|
Glyceryl trinitrate |
Tablet (sublingual): 500 micrograms |
100000 |
|
Hydralazine* |
Injection: 20 mg (hydrochloride) in ampoule |
15000 |
|
Hydralazine* |
Tablet: 25 mg (hydrochloride) |
100000 |
|
Hydralazine* |
Tablet: 50 mg (hydrochloride) |
100000 |
|
Hydrochlorothiazide |
Solid oral dosage form: 12.5 mg |
100000 |
|
Hydrochlorothiazide |
Solid oral dosage form: 25 mg |
100000 |
|
Isosorbide dinitrate(SR) |
Tablet (sublingual): 10mg |
2000000 |
|
Isosorbide dinitrate(SR) |
Tablet (sublingual): 20 mg |
2000000 |
|
Lidocaine |
Injection: 20 mg (hydrochloride)/ml in 5-ml ampoule |
100000 |
|
Methyldopa* |
Tablet: 250 mg |
500000 |
|
Metoprolol |
Injection: 1mg/5ml Ampoule |
15000 |
|
Metoprolol |
Tablet : 50 mg |
100000 |
|
Metoprolol |
Tablet: 200mg Slow release |
25000 |
|
Norepinephrine (Noradrenaline) |
Injection: 8mg/4ml 4-ml ampoule |
30000 |
|
Propranolol |
Tablet: 40mg |
250000 |
|
Propranolol |
Tablet: 10mg |
500000 |
|
Sodium nitroprusside |
Powder for infusion: 50 mg in ampoule |
500000 |
|
Streptokinase |
Powder for injection: 1.5 million IU in vial |
50000 |
|
Verapamil |
Tablet: 80 mg (hydrochloride) |
50000 |
|
Verapamil |
Injection: 2.5 mg (hydrochloride)/ml in 2-ml ampoule |
50000 |
|
Verapamil |
Injection 40 mg |
20000 |
|
12.6 Lipid-lowering agents |
|
|
|
Statin |
equivalent to simvastatin Tablet: 5 mg; |
100000 |
|
Statin |
equivalent to simvastatin Tablet:10 mg; |
100000 |
|
Statin |
equivalent to simvastatin Tablet:20 mg; |
100000 |
|
Statin |
equivalent to simvastatin Tablet:40mg; |
100000 |
|
13.DERMATOLOGICAL MEDICINES (TOPICAL) |
|||
Benzyl benzoate |
Lotion 25% |
100000 |
|
Betamethasone |
Cream 0,1% |
25000 |
|
Fucidic acid |
Cream 2% |
100000 |
|
Permethrine (anti-lice) |
Shampoo |
200000 |
|
Silver sulphadiazine |
Cream 1% |
100000 |
|
Trolamine |
Emulsion external use 0,67% |
10000 |
|
14. DIAGNOSTIC AGENTS |
|||
14.1 Ophthalmic medicines |
|||
Tropicamide |
Eye drops: 0.5%. |
25000 |
|
14.2 Radiocontrast media |
|||
Barium sulfate |
Aqueous suspension. |
10 000 KG |
|
Iohexol |
Injection: 140 mg to 350 mg iodine/ mL in 5‐ mL; 10‐mL; 20‐ mL ampoules. |
20000 |
|
15.DISINFECTANTS AND ANTISEPTICS |
|||
Chlorhexidine digluconate |
Solution 5% 1L Bottle |
10000 |
|
Polyvidone iodine |
Solution 10% |
100000 |
|
16.DIURETICS |
|||
Mannitol |
Injectable solution: 10% |
10000 |
|
Mannitol |
Injectable solution: 20% |
20000 |
|
Spironolactone |
Tablet: 25 mg |
100000 |
|
17.GASTROINTESTINAL MEDICINES |
|||
17.1 ANTIULCER MEDICINES |
|||
Omeprazole |
Solid oral dosage form: 10 mg |
100000 |
|
Omeprazole |
Solid oral dosage form: 20 mg |
100000 |
|
Omeprazole |
Solid oral dosage form:40 mg |
100000 |
|
Omeprazole |
Injection: 40 mg in 10 ml vial |
500000 |
|
Ranitidine |
Tablet 150 mg |
100000 |
|
Ranitidine |
Injection: 25mg/ml (HCL) in 2 ml ampoule |
1500000 |
|
17.2 ANTIEMETIC MEDICINES |
|||
Metoclopramide |
Injection: 10mg/2ml ampoule |
600000 |
|
Metoclopramide |
Tablet : 10 mg |
100000 |
|
Ondansetrone |
Injection: 4 mg |
300000 |
|
17.3 ANTI-INFLAMMATORY MEDICINES |
|||
Hydrocortisone |
Suppository: 25mg |
0 |
|
17.5 MEDICINES USED IN DIARRHOEA |
|||
Oral rehydration salts |
Powder for dilution |
1000000 |
|
17.5.2 Medicines for diarrhoea |
|||
Zinc sulfate |
Solid oral dosage form: 20 mg. |
5000 |
|
18.5 NSULINS AND OTHER MEDICINES USED FOR DIABETES |
|||
Glibenclamide |
Tablet: 5 mg |
1000000 |
|
Gliclazid |
Tables 80mg |
1000000 |
|
Insulin Mix 70/30 |
Injection: 100IU/ml, 10 ml vial |
100000 |
|
Insulin pens Mix-cartridge with needle, 100IU/ml, 3ml |
Box / 5 Cartridges |
50000 |
|
Insulin pens N-cartridge with needle, 100IU/ml, 3ml |
Box / 5 Cartridges |
40000 |
|
Insulin pens R- cartridge with needle, 100IU/ml, 3ml( special list)fifth quantity |
Box / 5 Cartridges |
40000 |
|
Insulin Rapid |
Injection : 100IU/ml, 10ml |
5000 |
|
Insulin N |
Injection |
2000 |
|
Insulin Tardum |
Injection: 100IU/ml, 10 ml |
10000 |
|
Medroxyprogesterone acetate |
Tablet: 5mg |
10000 |
|
Metformin |
Tablet: 850 mg (hydrochloride) |
500000 |
|
Metformin |
Tablet: 1000 mg (or 500) |
1000000 |
|
glucagon |
Injection: 1 mg/ mL. |
5000 |
|
18.8 THYROID HORMONS AND ANTITHYROID MEDICINES |
|||
Levothyroxine |
Tablet: 50 micrograms (sodium salt) |
50000 |
|
Levothyroxine |
Tablet: 100 micrograms (sodium salt) |
50000 |
|
Methimazole |
Tablet: 5mg |
80000 |
|
Propylthiouracil |
Tablet: 50mg |
0 |
|
19.1 DIAGNOSTIC AGENTS |
|||
Tuberculin, purified protein derivative (PPD) |
Injection: 1,5ml -10 UT- Ampoule |
1000 |
|
19.2 SERA AND IMMUNOGLOBULINS |
|||
Anti-D immunoglobulin (human) |
Injection: 250 micrograms in single-dose vial (IM) |
10000 |
|
Anti-D immunoglobulin (human) |
Injection: 250 micrograms (IV) |
1000 |
|
Antivenom immunoglobulin* |
Injection |
10000 |
|
Antivenom immunoglobulin* |
* Exact type to be defined locally ( Rabies) |
10000 |
|
20.MUSCLE RELAXANTS ( PERIPHERALLY -ACTING) AND CHOLIINESTERASE INHIBITORS |
|||
Atracurium |
Injection: 25mg/ml Besylate |
100000 |
|
Atracurium |
Injection: 10mg/ml Besylate |
100000 |
|
Neostigmine |
Tablet: 15 mg (bromide) |
100000 |
|
Neostigmine |
Injection: 2.5mg (metilsulfate) in 1-ml ampoule |
75000 |
|
Neostigmine |
Injection: 500 micrograms in 1-ml ampoule |
300000 |
|
Pyridoxine |
Tablet: 25 mg (hydrochloride) |
10000 |
|
Suxamethonium |
Powder For Injection: 50 mg (chloride)/ml in 2-ml ampoule |
10000 |
|
Vecuronium |
Powder for injection: 10 mg (bromide) in vial |
5000 |
|
Pyridostigmine |
Injection: 1 mg in 1-ml ampoule |
5000 |
|
Pyridostigmine |
Tablet: 60 mg (bromide) |
5000 |
|
Potassium chloride |
Syrup: 40 m Eq. Potassium per 30mL |
5000 |
|
21.OPHTALMOLOGICAL PREPERATIONS |
|||
Acetazolamide |
Tablet: 250 mg |
50000 |
|
Acyclovir |
Ointment 3% W/W |
25000 |
|
Atropine |
Solution (eye drops) 0.3% (sulfate) |
10000 |
|
Atropine |
Solution (eye drops) 0.5% (sulfate) |
10000 |
|
Atropine |
Solution (eye drops) 1% (sulfate) |
10000 |
|
Ciprofloxacin |
Eye ointment 1% |
10000 |
|
Pilocarpine |
Solution (eye drops) 2%; 4% (hydrochloride or nitrate) |
10000 |
|
Prednisolone |
Solution (eye drops) 0.5% (sodium phosphate) |
15000 |
|
Tetracaine |
Solution (eye drops) 0.5% (hydrochloride) |
10000 |
|
Tetracycline |
Eye ointment 1% (hydrochloride) |
20000 |
|
Timolol |
Solution (eye drops) 0.5% (as hydrogen maleate) |
200000 |
|
Tobramycine |
Ophthalmic drops 0.3% |
60000 |
|
Fluoresceine |
Ophthalmic |
5000 |
|
Gentamicin |
Solution (eye drops) 0.3% (sulfate) |
50000 |
|
22.OXYTOCICS AND ANTIOXYTOCICS |
|||
Ergometrine |
Injection: 200 micrograms (hydrogen maleate) in 1-ml ampoule |
150000 |
|
Misoprostol |
Tablet: 200 microgrames |
5000 |
|
Misoprostol |
Vaginal tablet: 25 microgrames |
5000 |
|
Nifedipine |
Immediate-release capsule: 10 mg |
15000 |
|
Oxytocin |
Injection: 10 IU in 1-ml |
500000 |
|
24.MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS |
|||
Benzhexol |
Tablet: 2mg |
20000 |
|
Benzhexol |
Tablet: 5mg |
20000 |
|
Carbamazepine |
Tablet (scored): 100 mg |
500000 |
|
Carbamazepine (SR) |
Tablet (scored): 200 mg |
1000000 |
|
Carbamazepine |
Tablet (scored): 400 mg |
1000000 |
|
Chlorpromazine |
Injection: 25 mg (hydrochloride)/ml in 2-ml ampoule |
10000 |
|
Fluoxetine |
Oral form: 20 mg (as hydrochloride) |
20000 |
|
Fluphenazine |
Injection: 25 mg (decanoate or enantate) in 1-ml ampoule |
20000 |
|
Haloperidol |
Injection: 5 mg in 1-ml ampoule |
20000 |
|
Haloperidol |
Tablet: 10 mg |
10000 |
|
Haloperidol |
Tablet: 5 mg |
10000 |
|
Lithium carbonate |
Solid oral dosage form: 300 mg |
50000 |
|
Valproic acid (sodium valproate) |
Tablet (enteric-coated):200 mg |
10000 |
|
Valproic acid (sodium valproate) |
Tablet (enteric-coated):500 mg |
10000 |
|
Valproic acid (sodium valproate) |
Oral Liquid 200mg/5ml |
10000 |
|
Clomipramine |
Capsule: 10 mg (hydrochloride) |
25000 |
|
Haloperidol |
Oral drops |
50000 |
|
Clomipramine |
Capsule: 25 mg (hydrochloride) |
100000 |
|
Amitriptylin |
Tablets 10mg |
10000 |
|
Amitriptylin |
Tablets 25mg |
10000 |
|
Clozapin |
Talets 25mg |
50000 |
|
Clozapin |
Tablets 100mg |
50000 |
|
Risperidone |
Solid oral dosage form: 4 mg |
25000 |
|
25 .RESPIRATORY TRACT MEDICINES |
|||
25.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease |
|||
Budesonide |
Inhalation (aerosol): 100 micrograms per dose |
25000 |
|
Budesonide |
Inhalation (aerosol): 200 micrograms per dose |
25000 |
|
Beclomethazone dipropionate |
Nasal Spray: 50mcg/puff |
300000 |
|
Ipratropium bromide |
Inhalation aerosol 20 micrograme/ etered dose |
400000 |
|
Salbutamol |
Inhalation (aerosol): 100 micrograms (as sulfate) per dose |
150000 |
|
Salbutamol |
Injection: 0,5mg/ml |
100000 |
|
Salbutamol |
Respirator solution for use in nebulizers: 5 mg (as sulfate)/ml |
50000 |
|
Dextromethorphane hydrobromide 10mg+Chlorpheniramine maleate 2mg Syr |
Syrup 10mg/2 mg |
0 |
|
26.SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID-BASE DISTURBANCES |
|||
Glucose |
Injectable solution: 5% (isotonic) 1L |
3000000 |
|
Glucose |
Injectable solution: 10% (hypertonic) 1L |
100000 |
|
Glucose |
Injectable solution:; 50% (hypertonic) |
5000 |
|
Glucose with sodium chloride |
Injectable solution: 4% glucose, 0.18% sodium chloride(equivalent to Na+ 30 mmol/L, Cl- 30 mmol/L) 1L |
3000000 |
|
|
|
325000 |
|
Potassium chloride |
injectable Solution: 11.2% in 20-ml ampoule. (equivalent to K+ 1.5 mmol/ml, Cl- 1.5 mmol/ml). |
100000 |
|
Potassium chloride |
Tablet: 600mg |
25000 |
|
Potassium chloride |
Syrup 40 m Eq. Potassium per 30ml |
25000 |
|
Sodium bicarbonate |
Injectable solution: 1.4% isotonic (equivalent to Na+ 167 mmol/L, HCO3- 167 mmol/L). |
100000 |
|
Sodium chloride |
Injectable solution: 0.9% isotonic (equivalent to Na+ 154 mmol/L, Cl- 154 mmol/L).1L |
5000000 |
|
Sodium lactate, compound solution |
Injectable solution |
100000 |
|
26.3 Miscellaneous |
|||
water for injection |
5‐ mL ampoule |
1000000 |
|
27.VITAMINS AND MINERALS |
|||
Ascorbic acid |
Tablet: 500 mg |
100000 |
|
B- complex |
Tablet: B1+B6+B12 |
100000 |
|
B- complex |
Injection |
200000 |
|
Calcium gluconate |
Injection: 100 mg/ml in 10-ml ampoule |
50000 |
|
Cholecalciferol |
Oral liquid: 400 IU/ml |
2000000 |
|
Cholecalciferol |
Solid oral dosage form: 400 IU |
1000000 |
|
Cholecalciferol |
Solid oral dosage form: 1000 IU |
500000 |
|
Nicotinamide |
Tablet: 50 mg |
100000 |
|
Retinol |
Capsule: 50 000 IU; (as palmitate) |
100000 |
|
Retinol |
Capsule: 100 000 IU(as palmitate) |
100000 |
|
Retinol |
Capsule: 200 000 IU (as palmitate) |
100000 |
|
Retinol |
Oral oily solution: 100 000 IU (as palmitate)/ml in multidose dispenser. |
100000 |
|
Retinol |
Tablet (sugar-coated): 10 000 IU (as palmitate) |
100000 |
|
Retinol |
Water-miscible injection: 100 000 IU (as palmitate) inJ 2ml ampoule |
100000 |
|
Riboflavin |
Tablet: 5 mg |
100000 |
|
calcium |
Tablet: 500 mg (elemental) |
1000000 |
|
Thiamine |
Tablet: 50 mg (hydrochloride) |
100000 |
|
29. SPECIFIC MEDICINES FOR NEONATAL CARE |
|||
29.1 Medicines administered to the neonate |
|||
caffeine citrate |
Injection: 20 mg/ mL (equivalent to 10 mg caffeinebase/ mL). |
5000 |
|
surfactant |
Suspension for intratracheal instillation: 25 mg/ Ml |
10000 |
|
30. MEDICINES FOR DISEASES OF JOINTS |
|||
30.2 Disease-modifying agents used in rheumatoid disorders (DMARDs) |
|||
Penicillamine |
Solid oral dosage form: 250 mg. |
80000 |
|
Total estimated cost for EML 2019 USD 129,782,444 |
ANNEX 2 |
|||
Special Medicines List 2019 |
|||
Anti- Cancer Drugs |
|||
# |
Item |
Description |
Needs 2019 |
1 |
Anastrazol |
1mg/ Tablet |
100,000 |
2 |
Busulfan |
2mg/ Tablet |
1,000 |
3 |
Busulfan |
5 mg/vial |
10 |
4 |
Epirubicine |
10mg /vial |
5,000 |
5 |
Epirubicine |
50mg/ vial |
5,000 |
6 |
Exemestane |
25mg/ Tablet |
50,000 |
7 |
Flutamide |
250mg/ Tablet |
100,000 |
8 |
Goserelin |
10.8 mg / dose prefilled syringe |
2,000 |
9 |
Goserelin |
3.6 mg prefilled syringe |
2,200 |
10 |
Melphalan |
2 mg /Tablet |
20,000 |
11 |
Melphalan |
50 mg /vial |
100 |
12 |
Mitoxantrone |
10 mg /vial |
400 |
13 |
Octreotide LAR |
30 mg / vial |
550 |
14 |
Octreotide acetate |
0.1 mg/ml amp |
850 |
15 |
valganciclovir Tabs |
Tablet: 450 mg |
2,000 |
16 |
Temozolomide |
Tablet :100 mg |
3,000 |
17 |
Temozolomide |
Tablet 250 mg |
3,000 |
18 |
Thalidomide |
Tablet :50 mg |
10,000 |
19 |
Thalidomide |
Tablet :100 mg |
10,000 |
20 |
Topotecan vial |
4mg |
1,000 |
21 |
Letrozole |
Tablet : 2,5mg |
100,000 |
22 |
Cetuximab |
Inj :5 mg/ml in 20 ml |
12,000 |
23 |
Pazopanib |
Tablet : 400mg |
35,000 |
24 |
Pazopanib |
Tablet : 200mg |
10,000 |
25 |
Sorafenib |
Tablet : 200mg |
120,000 |
26 |
Sorafenib |
Tablet : 400mg |
0 |
27 |
Vemurafenib |
Tablet : 240 mg |
14,000 |
28 |
Pemetrexed 500 mg |
Tablet : 500 mg |
1,000 |
29 |
Sunitinib |
Capsule : 50 mg |
11,000 |
30 |
Fulvestrant |
Inj : 250 mg/5 ml |
1,500 |
31 |
Fulvestrant |
Inj : 500 mg/5 ml |
0 |
32 |
Everolimus |
Tablet : 5 mg |
8,000 |
33 |
Everolimus |
Tablet : 10 mg |
6,000 |
34 |
Everolimus |
Tablet : 0.75mg |
105,000 |
35 |
Erlotinib |
Tablet :150 mg |
4,000 |
36 |
Fingolimod |
Capsule : 0,5 mg |
5,000 |
37 |
Natalizumab |
Inj : 300 mg in 15 ml |
0 |
38 |
Bevacizumab |
100mg vial |
2,500 |
39 |
Bevacizumab |
400mg vial |
1,500 |
4O |
Bicalutamide |
50mg Tab |
110,000 |
41 |
Bortezomib |
3.5mg amp |
1,600 |
42 |
Bortezomib |
1mg vial |
300 |
43 |
Carmustine |
40mg Tab |
0 |
44 |
Carmustine |
50mg injection |
30 |
45 |
Carmustine |
100mg injection |
30 |
46 |
Cladribine |
10 MG vial |
500 |
47 |
Etanercept |
25 mg amp |
4,000 |
48 |
Gefitinib |
250mg Tab |
10,000 |
49 |
Golimumab |
50 mg prefilled injection |
4,000 |
50 |
Idarubicin |
5 mg vial |
700 |
51 |
Idarubicin |
10mg vial |
540 |
52 |
Idarubicin |
20mg vial |
400 |
53 |
Lapatinib |
250mg Tab |
15,000 |
54 |
Lenalidomide |
10 mg Tab |
8,000 |
55 |
Leuprolide |
7.5 mg vial |
300 |
56 |
Regorafenib |
40 mg Tab |
15,000 |
57 |
Triptorelin acetate |
3.75 mg amp |
1,000 |
58 |
Triptorelin Acetate |
0.1 mg amp |
1,000 |
59 |
Vinflunine ditratrate |
50mg/2ml vial |
500 |
60 |
Vinflunine ditratrate |
250mg/100ml vial |
700 |
Estimated total cost USD 31,079,950 |
|||
|
|||
Other Medicines |
|||
# |
Item |
Description |
Need 2019 |
1 |
Smof Kabiven |
Bag |
30,000 |
2 |
Kabiven |
Bag |
7,000 |
3 |
Voluven 6% |
Bag |
75,000 |
4 |
Fluticazone 120 doses |
Inhaler :50 microgr/dose |
10,000 |
5 |
Salmeterol 120 doses |
Inhaler :25 microgr par dose |
10,000 |
6 |
Formotérol |
Inhaler :12 microgr |
2,500 |
7 |
Olodatérol |
2,5 Microgr |
2,500 |
8 |
Omalizumab |
Inj :150 mg |
1,000 |
9 |
Dornase alfa |
Inhaler :500 U/2,5 ml |
0 |
10 |
Iloprost |
Inhaler :10 microgr/ml |
0 |
11 |
Tociluzumab |
Inj : 162mg |
800 |
12 |
Infliximab |
Vial 100 mg |
7,000 |
13 |
Rocuronium bromide |
Inj : 50mg/5ml |
5,000 |
14 |
Pancuronium |
Inj : 2mg/ml |
1,000 |
15 |
Tirofiban |
Inj :50 microgram per ml |
1,000 |
16 |
Nitroglycerin |
spray |
0 |
17 |
Nitroglycerin |
Patch : 5mg |
40,000 |
18 |
Nitroglycerin |
Patch :10mg |
40,000 |
19 |
Basiliximab Iv |
Inj : 20 microgr |
100 |
20 |
Pramipexol |
Tablet: 0.18 |
0 |
21 |
Pramipexol |
Tablet:0.35 |
0 |
22 |
linezolid |
Injection for intravenous administration: 2 mg/ mLin 300 mL bag |
10,000 |
23 |
levodopa, carbidopa, entacapone STALEVO (B/100 tabs) |
Tablet:200 mg/50 mg/200 mg |
30,000 |
24 |
Clonazepam |
Tablet : 1 mg |
50,000 |
25 |
Levetiracetam |
Tablet : 500mg |
25,000 |
26 |
Levetiracetam |
Oral Susp :300mg |
0 |
27 |
Levetiracetam |
500 mg/5ml amp |
0 |
Estimated total cost USD 8,146,000 |
ANNEX 3 |
||||
Hospital supplies and Equipment 2019 |
||||
Description |
Quantity |
Total Quantities |
||
MOH |
MOHE |
|||
1 |
Renal dialysis consumable kits Fresenius or Gambro- B Braun) |
600,000 |
||
2 |
Renal dialysis machine (Gambro or B Braun or Fresenius ) |
150 |
150 |
300 |
3 |
Oxygenator max flow rate 2 with circuate |
0 |
150 |
150 |
4 |
Oxygenator max flow rate 2.5 with circuate |
0 |
150 |
150 |
5 |
Oxygenator max flow rate 3 with circuate |
1000 |
150 |
1150 |
6 |
Oxygenator max flow rate 5 with circuate |
1000 |
150 |
1150 |
7 |
Oxygenator max flow rate more than 5 with circuate |
2000 |
150 |
2150 |
8 |
Water purification unit for kidney dialysis- 1 staions for each 4-5 machines |
35 |
25 |
60 |
9 |
Fucidic acid Gauze Sterile Gauze |
50000 |
30000 |
80000 |
10 |
ventilator ,infant , neonatal |
25 |
15 |
40 |
11 |
Ventilator adult |
100 |
50 |
150 |
12 |
Nebulizer with 100 filters |
74 |
0 |
74 |
13 |
Color Doppler Echo Machine |
15 |
10 |
25 |
14 |
Mobile X-ray machine |
10 |
4 |
14 |
15 |
X-ray machine basic |
10 |
5 |
15 |
16 |
C-Arm X ray Machine |
10 |
5 |
15 |
17 |
Radiographic basic system with floating table unit and protection X- RAY Apron Supplier: Siemens, GE, Philips, BMI |
5 |
2 |
7 |
18 |
Radiographic/ Fluoroscopic, general purpose unit |
5 |
1 |
6 |
19 |
Incubator - baby incubator |
100 |
50 |
150 |
20 |
Phototherapy unit mobile for baby incubator-Independent |
50 |
30 |
80 |
21 |
ICU incubator with monitor |
25 |
5 |
30 |
22 |
Mobile baby Incubator |
5 |
5 |
|
23 |
Operating Table General |
20 |
10 |
30 |
24 |
Orthopedic surgical table with traction |
15 |
4 |
19 |
25 |
Neurosurgical operations table |
2 |
1 |
3 |
26 |
Otology Microscope |
2 |
2 |
4 |
27 |
Ophthalmology Microscope |
7 |
5 |
12 |
28 |
Neurosurgery Microscope |
6 |
5 |
11 |
29 |
Operating suction machine |
100 |
50 |
150 |
30 |
Freezer -80 C with alarm & monitor |
10 |
2 |
12 |
31 |
YAG Laser for Ophthalmology |
4 |
2 |
6 |
32 |
Multi- 6 Channel ECG |
20 |
20 |
40 |
33 |
Multi- 12 Channel ECG |
20 |
20 |
40 |
34 |
Defibrillator |
40 |
10 |
50 |
35 |
Elisa Reader and washer analyzer |
4 |
1 |
5 |
36 |
Total Hormones ANALYSER |
3 |
1 |
4 |
37 |
Steam sterilizer capacity vertical 200 L |
15 |
8 |
23 |
38 |
High Speed steam Sterilizer (20L) |
40 |
15 |
55 |
39 |
Ambulances |
100 |
30 |
130 |
40 |
Oxygen Generator central unit for different hospital sizes |
30 |
5 |
35 |
41 |
Oxygen generator unit 20 m 3 / hour |
6 |
3 |
9 |
42 |
Computed Tomography Multislices (CT. Multislices) |
4 |
3 |
7 |
43 |
Echography machine ( ob/gyncology) |
20 |
5 |
25 |
44 |
Anesthesia Machine |
50 |
30 |
80 |
45 |
Anesthesia Machine ( with digital mixer and digital flowmeter) |
6 |
6 |
12 |
46 |
Complete colonoscopy unit |
6 |
2 |
8 |
47 |
Upper and lower complete gastroscopy unit(tower - light source with camera) |
6 |
2 |
8 |
48 |
Mobile Ventilator |
10 |
10 |
20 |
49 |
Automatic Syringe Pump |
200 |
100 |
300 |
50 |
Endometrial Telescope Unit with Bipolar Electro Surgery unit and all accessories |
10 |
2 |
12 |
51 |
Hematology Analyzers Automated(3 part differential for leucoytes) |
8 |
2 |
10 |
52 |
Clinical Chemistry Analyzer Automated 400 Test/H |
12 |
6 |
18 |
53 |
Spectrophotometer |
20 |
0 |
20 |
54 |
Electrophoresis HPLC |
5 |
0 |
5 |
55 |
Hemoglobin apphersis cappillay |
5 |
0 |
5 |
56 |
Microscope complete |
15 |
5 |
20 |
57 |
Microhematocrit centrifuge |
15 |
5 |
20 |
58 |
Centrifuge for tube 15ml &50 ml |
15 |
5 |
20 |
59 |
Non invasive Bilirubin analyzer for newborn |
3 |
0 |
3 |
60 |
Blood bags Refrigerator with monitor and alarm- capacity 100-120 bags |
50 |
10 |
60 |
61 |
Electrolyte analyzer |
10 |
5 |
15 |
62 |
Blood gaz analyzer |
8 |
8 |
16 |
63 |
Germ incubator capacity to be specified |
10 |
0 |
10 |
64 |
Digital Workstation for x-ray films ( CR) |
20 |
5 |
25 |
65 |
Magnetic Resonance Imaging (MRI) |
4 |
2 |
6 |
66 |
Electro Surgery unit EUS |
20 |
5 |
25 |
67 |
Operating room Ceiling Light with two arms |
50 |
20 |
70 |
68 |
Operating room Mobile Light with battery |
100 |
20 |
120 |
69 |
UPS units for hospital department capacity to be specified |
200 |
100 |
300 |
70 |
Laboratory incubator |
2 |
0 |
2 |
71 |
Safety cabinet class 2 |
2 |
0 |
2 |
72 |
Shaker for sputum with incubator |
2 |
0 |
2 |
73 |
Real time PCR |
2 |
0 |
2 |
74 |
Gene expert 3000 kit machine |
2 |
0 |
2 |
75 |
Pasteur oven |
2 |
0 |
2 |
76 |
Inspissator for bacterial media- specifications to be identified |
2 |
0 |
2 |
77 |
Heart and lung machine with heater cooler |
3 |
3 |
6 |
78 |
Intra aortic balloon pump |
3 |
1 |
4 |
79 |
vein illuminator |
20 |
10 |
30 |
80 |
Cardiac cath- lab |
1 |
1 |
2 |
Estimated total cost USD : 180,000,000 |
ANNEX 4 |
||
Medical kits |
||
Description |
Unit of Measure |
Qty |
Burn Dressing Kit without Silver Sulphadiazine cream |
Kit |
Quantities will be defined upon country needs |
Burn Dressing Kit with Silver Sulphadiazine cream |
kit |
|
KIT, SURGICAL SUPPLY |
Kit |
|
KIT, SURGICAL INSTRUMENT, MINOR |
Kit |
|
KIT, SURGICAL INSTRUMENT, MAJOR |
Kit |
|
KIT, TRAUMA - A |
Kit |
|
KIT, TRAUMA - B |
Kit |
|
First Aid Kit |
Kit |
|
KIT, CHOLERA HARDWARE (6), complete |
Kit |
|
KIT, CHOLERA COMMUNITY (3), complete |
Kit |
|
KIT, CHOLERA CENTRAL REFERENCE (1), complete |
Kit |
|
KIT, FAMILY DOCTOR'S PRACTICE |
Kit |
|
IEHK 2017 - Complete |
Kit |
|
IEHK 2017- Basic unit without antimalarial medicines |
Kit |
|
NCDK 2016 Complete |
Kit |
ANNEX 5 |
||
Vaccines 2019 |
||
# |
Item |
Need Qty 2019 |
1 |
BCG |
0 |
2 |
BCG Live ( intravesical ) |
900 |
3 |
ACYW meningococcal meningitis vaccine |
750000 |
4 |
Anti Rabies Serum |
15000 |
5 |
antitetanus immunoglobulin |
25000 |
6 |
antitetanus Serum |
25000 |
7 |
DT (1 dose vial ) |
0 |
8 |
DTPa (1 dose vial ) |
0 |
9 |
haemophilus influenza type b vaccine |
10000 |
10 |
hepatitis A vaccine |
10000 |
11 |
hepatitis A Adult vaccine |
5000 |
12 |
hepatitis B vaccine |
0 |
13 |
hepatitis B Adult vaccine |
0 |
14 |
influenza vaccine |
250000 |
15 |
Rabies vaccine |
40000 |
16 |
Rotavirus vaccine |
0 |
17 |
typhoid vaccine |
0 |
18 |
yellow fever vaccine |
1500 |
19 |
Chickenpox Vaccine |
10000 |
20 |
MMR (1 dose vial ) |
0 |
21 |
OPV (20 Dose ) |
0 |
22 |
Pentaxin Vaccine |
0 |
23 |
Pneumococcal Vaccine PCV13 |
5000 |
24 |
Pneumococcal Vaccine PPSV23 |
5000 |
25 |
Teramix Vaccine( 1 Dose Vial ) |
0 |
26 |
TRI TAN RIX ( 1 Dose Vial ) |
0 |
HeRams 2014
The publications posted on this web page were produced with the support of WHO. They are not official publications of WHO. The designations employed and the presentation of the material in these publications do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
EWARS Weekly Bulletin 2015
EWARS weekly Bulletin, week No 52 [pdf 690kb]
EWARS weekly Bulletin, week No 51 [pdf 690kb]
EWARS weekly Bulletin, week No 50 [pdf 690kb]
EWARS weekly Bulletin, week No 49 [pdf 693kb]
EWARS weekly Bulletin, week No 48 [pdf 695kb]
EWARS weekly Bulletin, week No 47 [pdf 794kb]
EWARS weekly Bulletin, week No 46 [pdf 854kb]
EWARS weekly Bulletin, week No 45 [pdf 770kb]
EWARS weekly Bulletin, week No 44 [pdf 927kb]
EWARS weekly Bulletin, week No 43 [pdf 773kb]
EWARS weekly Bulletin, week No 42 [pdf 908kb]
EWARS weekly Bulletin, week No 41 [pdf 787kb]
EWARS weekly Bulletin, week No 40 [pdf 779kb]
EWARS weekly Bulletin, week No 39 [pdf 700kb]
EWARS weekly Bulletin, week No 38 [pdf 774kb]
EWARS weekly Bulletin, week No 37 [pdf 839kb]
EWARS weekly Bulletin, week No 36 [pdf 706kb]
EWARS weekly Bulletin, week No 35 [pdf 761kb]
EWARS weekly Bulletin, week No 34 [pdf 807kb]
EWARS weekly Bulletin, week No 33 [pdf 901kb]
EWARS weekly Bulletin, week No 32 [pdf 910kb]
EWARS weekly Bulletin, week No 31 [pdf 874kb]
EWARS weekly Bulletin, week No 30 [pdf 875kb]
EWARS weekly Bulletin, week No 29 [pdf 693kb]
EWARS weekly Bulletin, week No 28 [pdf 700kb]
EWARS weekly Bulletin, week No 27 [pdf 772kb]
EWARS weekly Bulletin, week No 26 [pdf 766kb]
EWARS weekly Bulletin, week No 25 [pdf 694kb]
EWARS weekly Bulletin, week No 24 [pdf 769kb]
EWARS weekly Bulletin, week No 23 [pdf 969 kb]
EWARS weekly Bulletin, week No 22 [pdf 693kb]
EWARS weekly Bulletin, week No 21 [pdf 805kb]
EWARS weekly Bulletin, week No 20 [pdf 796kb]
EWARS weekly Bulletin, week No 19 [pdf 763kb]
EWARS weekly Bulletin, week No 18 [pdf 851kb]
EWARS weekly Bulletin, week No 17 [pdf 825kb]
EWARS weekly Bulletin, week No 16 [pdf 770kb]
EWARS weekly Bulletin, week No 15 [pdf 818kb]
EWARS weekly Bulletin, week No 14 [pdf 741kb]
EWARS weekly Bulletin, week No 13 [pdf 678kb]
EWARS weekly Bulletin, week No 12 [pdf 654kb]
EWARS weekly Bulletin, week No 11 [pdf 758 kb]
EWARS weekly Bulletin, week No 11 [pdf 758 kb]
EWARS weekly Bulletin, week No 10 [pdf 750 kb]
EWARS weekly Bulletin, week No 9 [pdf 661kb]
EWARS Bulletin, January 2015 [pdf 575kb]
EWARS weekly Bulletin, week No 8 [pdf 591kb]
EWARS weekly Bulletin, week No 7 [pdf 593kb]
EWARS weekly Bulletin, week No 6 [pdf 660kb]
EWARS weekly Bulletin, week No 5 [pdf 657kb]
EWARS weekly Bulletin, week No 4 [pdf 667kb]
EWARS weekly Bulletin, week No 3 [pdf 246kb]